Effect of lipid-lowering strategies on tubular cell biology

Kidney International, Supplement

Volumn 56, Issue 71, 1999, Pages

  Vrtovsnik, François ^a,b   Essig, Marie ^a   Iimura, Osamu ^a   Friedlander, Gérard ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSERM   (France)

Author keywords

Apoptosis; Cell proliferation; Fibrinolysis; Isoprenylation; Lovastatin

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; PLASMINOGEN ACTIVATOR; ANTILIPEMIC AGENT; CELL NUCLEUS ANTIGEN; MEVALONIC ACID; MEVINOLIN; PROTEIN C FOS; PROTEIN P21; PYROPHOSPHORIC ACID DERIVATIVE; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL; APOPTOSIS; CELL DIVISION; CYTOLOGY; DRUG EFFECT; KIDNEY PROXIMAL TUBULE; METABOLISM; REVIEW; ACTIN FILAMENT; ANIMAL CELL; CELL PROLIFERATION; CONFERENCE PAPER; DISEASE COURSE; DNA SYNTHESIS; DRUG MECHANISM; FIBRINOLYSIS; FIBROSIS; ISOPRENYLATION; KIDNEY CYST; KIDNEY DISEASE; KIDNEY TUBULE CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTICHOLESTEREMIC AGENTS; APOPTOSIS; CELL DIVISION; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KIDNEY TUBULES, PROXIMAL; PLASMINOGEN ACTIVATORS;

EID: 0033050560     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. RISDON RA, SLOPER JC, DE WARDENER HE: Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis. Lancet 7564:363-366, 1968
2. HOWIE AJ, ROWLANDS DC, REYNOLDS GM, BARNES AD: Measurement of proliferation in renal biopsy specimens: Evidence of subclinical tubular damage in the nephrotic syndrome. Nephrol Dial Transplant 10:2212-2218, 1995
3. FINE LG, HAMMERMAN MR, ABBOUD HE: Evolving role of growth factors in the renal response to acute and chronic disease. J Am Soc Nephrol 2:1163-1170, 1992
4. TERZI F, TICOZZI C, BURTIN M, MOTEL V, BEAUFILS H, LAOUARI D, ASSAEL BM, KLEINKNECHT C: Subtotal but not unilateral nephrectomy induces hyperplasia and protooncogene expression. Am J Physiol 268:F793-F801, 1995
5. TRUDEL M, D'AGATI V, COSTANTINI F: C-myc as an inducer of polycystic kidney disease in transgenic mice. Kidney Int 39:665-671, 1991
6. GOLDSTEIN JL, BROWN MS: Regulation of the mevalonate pathway. Nature 343:425-430, 1990
7. GRANDALIANO G, BISWAS P, CHOUDHURY GO, ABBOUD HE: Simvastatin inhibits PDGF-induced DNA synthesis in human glomerular mesangial cells. Kidney Int 44:503-508, 1993
8. KIM SY, GUIJARRO C, O'DONNELL MP, KASISKE BL, KIM Y, KEANE WF: Human mesangial cell production of monocyte chemoattractant protein-1: Modulation by lovastatin. Kidney Int 48:363-371, 1995
9. GUIJARRO C, KIM Y, SCHOONOVER CM, MASSY ZA, O'DONNELL MP, KASISKE BL, KEANE WF, KASHTAN CE: Lovastatin inhibits lipopolysaccharide-induced NF-kappaB activation in human mesangial cells. Nephrol Dial Transplant 11:990-996, 1996
10. ISHIKAWA S, KAWASUMI M, SAITO T: Simvastatin inhibits the cellular signaling and proliferative action of arginine vasopressin in cultured rat glomerular mesangial cells. Endocrinology 136:1954-1961, 1995
11. STREATHER CP, OWEN JS, HENDRY BM, SCOBLE JE: Incubation of porcine high-density lipoprotein with the apical surface of LLC-PK1 renal tubular cells sustains the properties of orientated monolayers. Nephrol Dial Transplant 11:431-437, 1996
12. MIQUEL K, PRADINES A, SUN J, QIAN Y, HAMILTON AD, SEBTI SM, FAVRE G: GGTI-298 induces G0-G1 block and apoptosis whereas FTI-277 causes G2-M enrichment in A549 cells. Cancer Res 57:1846-1850, 1997
13. GIBBS JB, POMPLIANO DL, MOSSER SD, RANDS E, LINGHAM RB, SINGH SB, SCOLNICK EM, KOHL NE, OLIFF A: Selective inhibition of farnesyl-protein transferase blocks ras processing in vivo. J Biol Chem 268:7617-7620, 1993
14. TERADA Y, INOSHITA S, NAKASHIMA O, YAMADA T, KUWAHARA M, SASAKI S, MARUMO F: Lovastatin inhibits mesangial cell proliferation via p27Kip1. J Am Soc Nephrol 9:2235-2243, 1998
15. GHOSH PM, MOTT GE, GHOSH-CHOUDHURY N, RADNIK RA, STAPLETON ML, GHIDONI JJ, KREISBERG JI: Lovastatin induces apoptosis by inhibiting mitotic and post-mitotic events in cultured mesangial cells. Biochim Biophys Acta 1359:13-24, 1997
16. O'DONNELL MP, KASISKE BL, KATZ SA, SCHMITZ PG, KEANE WF: Lovastatin but not enalapril reduces glomerular injury in Dahl salt-sensitive rats. Hypertension 20:651-658, 1992
17. KASISKE BL, O'DONNELL MP, GARVIS WJ, KEANE WF: Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chronic renal failure. Circ Res 62:367-374, 1988
18. KASISKE BL, O'DONNELL MP, CLEARY MP, KEANE WF: Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney Int 33:667-672, 1988
19. HARRIS KPG, PURKERSON ML, YATES J, KLAHR S: Lovastatin ameliorates the development of glomerulosclerosis and uremia in experimental nephrotic syndrome. Am J Kidney Dis 15:16-23, 1990
20. GILE RD, COWLEY BD, GATTONE VH, O'DONNELL MP, SWAN SK, GRANTHAM JJ: Effect of lovastatin on the development of polycystic kidney disease in the Han:SPRD rat. Am J Kidney Dis 26:501-507, 1995
21. GLAZER AA, INMAN SR, STOWE NT, NOVICK AC: Renal microcirculatory effects of lovastatin in a rat model of reduced renal mass. Urology 50:812-317, 1997
22. PARK YS, GUIJARRO C, KIM Y, MASSY ZA, KASISKE BL, KEANE WF, O'DONNELL MP: Lovastatin reduces glomerular macrophage influx and expression of monocyte chemoattractant protein-1 mRNA in nephrotic rats. Am J Kidney Dis 31:190-194, 1998
23. YOSHIMURA A, INUI K, NEMOTO T, UDA S, SUGENOYA Y, WATANABE S, YOKOTA N, TAIRA T, IWASAKI S, IDEURA T: Simvastatin suppresses glomerular cell proliferation and macrophage infiltration in rats with mesangial proliferative nephritis. J Am Soc Nephrol 9:2027-2039, 1998
24. VRTOVSNIK F, COUETTE S, PRIE D, LALLEMAND D, FRIEDLANDER G: Lovastatin-induced inhibition of renal epithelial tubular cell proliferation involves a p21ras activated, AP-1 dependent pathway. Kidney Int 54:1016-1027, 1997
25. IIMURA O, VRTOVSNIK F, TERZI F, FRIEDLANDER G: HMG-CoA reductase inhibitors induce apoptosis in mouse proximal tubular cells in primary culture. Kidney Int 54:962-972, 1997
26. ESSIG M, VRTOVSNIK F, NGUYEN G, SRAER JD, FRIEDLANDER G: Lovastatin modulates in vivo and in vitro the plasminogen activator/plasmin system of rat proximal tubular cells: Role of geranylgeranylation and rho proteins. J Am Soc Nephrol 9:1377-1388, 1998
27. CASEY PJ: Protein lipidation in cell signaling. Science 268:221-225, 1995